SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001723128-23-000009
Filing Date
2023-03-03
Accepted
2023-03-03 17:08:23
Documents
151
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrx-20221231.htm   iXBRL 10-K 4520458
2 EX-21.1 amrx2022311210-kexx211.htm EX-21.1 17937
3 EX-23.1 amrx-2022123110xkexx231.htm EX-23.1 5268
4 EX-31.1 amrx-2022123110xkexx311.htm EX-31.1 10817
5 EX-31.2 amrx-2022123110xkexx312.htm EX-31.2 10803
6 EX-31.3 amrx-2022123110xkexx313.htm EX-31.3 10871
7 EX-32.1 amrx-2022123110xkexx321.htm EX-32.1 5820
8 EX-32.2 amrx-2022123110xkexx322.htm EX-32.2 5747
9 EX-32.3 amrx-2022123110xkexx323.htm EX-32.3 5957
15 amrx-20221231_g1.jpg GRAPHIC 296898
  Complete submission text file 0001723128-23-000009.txt   22462545

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20221231.xsd EX-101.SCH 154209
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20221231_cal.xml EX-101.CAL 162135
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20221231_def.xml EX-101.DEF 773157
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20221231_lab.xml EX-101.LAB 1545848
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20221231_pre.xml EX-101.PRE 1073567
145 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20221231_htm.xml XML 4371287
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38485 | Film No.: 23705565
SIC: 2834 Pharmaceutical Preparations